File: /home/govancoz/mail/.spam/new/1718028292.M396108P890740.zacp120.ve.host,S=5554,W=5667
Return-Path: <solny@trabik.com>
Delivered-To: govancoz+spam@zacp120.ve.host
Received: from zacp120.ve.host
by zacp120.ve.host with LMTP
id IK9RFgQIZ2Z0lw0AvcbEzQ
(envelope-from <solny@trabik.com>)
for <govancoz+spam@zacp120.ve.host>; Mon, 10 Jun 2024 16:04:52 +0200
Return-path: <solny@trabik.com>
Envelope-to: cheryl@govan.co.za
Delivery-date: Mon, 10 Jun 2024 16:04:52 +0200
Received: from beta.ihs.cz ([77.237.134.12]:53848)
by zacp120.ve.host with esmtp (Exim 4.97.1)
(envelope-from <solny@trabik.com>)
id 1sGfdi-00000003lJv-0xkN
for cheryl@govan.co.za;
Mon, 10 Jun 2024 16:04:52 +0200
Received: from localhost (localhost [127.0.0.1])
by beta.ihs.cz (Postfix) with ESMTP id 1AE8D1470EC0;
Mon, 10 Jun 2024 05:56:24 +0200 (CEST)
X-Virus-Scanned: Debian amavisd-new at beta.ihs.cz
Received: from beta.ihs.cz ([127.0.0.1])
by localhost (beta.ihs.cz [127.0.0.1]) (amavisd-new, port 10024)
with ESMTP id bp5wOlDrjOGO; Mon, 10 Jun 2024 05:56:23 +0200 (CEST)
Received: from [192.168.1.17] (unknown [197.232.126.205])
(Authenticated sender: solny@trabik.com)
by beta.ihs.cz (Postfix) with ESMTPA id 4008A1470A58;
Mon, 10 Jun 2024 05:42:53 +0200 (CEST)
Content-Type: multipart/alternative; boundary="===============0715047031=="
MIME-Version: 1.0
To: Recipients <solny@trabik.com>
From: "Dr. Yasunobu Otsuga" <solny@trabik.com>
Date: Mon, 10 Jun 2024 06:42:43 +0300
Reply-To: dr.yotsugadaito@gmail.com
Message-Id: <20240610035624.1AE8D1470EC0@beta.ihs.cz>
X-Spam-Status: Yes, score=6.0
X-Spam-Score: 60
X-Spam-Bar: ++++++
X-Spam-Report: Spam detection software, running on the system "zacp120.ve.host",
has identified this incoming email as possible spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Hello I'm Dr. Yasunobu Otsuga, CEO of Daito Pharmaceutical,
a leading company based in Japan. Currently, we're in search of a qualified
individual to serve as our representative in South Africa for mi [...]
Content analysis details: (6.0 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 RCVD_IN_VALIDITY_SAFE_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[77.237.134.12 listed in sa-accredit.habeas.com]
0.5 SUBJ_ALL_CAPS Subject is all capitals
0.0 HTML_MESSAGE BODY: HTML included in message
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[77.237.134.12 listed in bl.score.senderscore.com]
2.0 PYZOR_CHECK Listed in Pyzor
(https://pyzor.readthedocs.io/en/latest/)
0.0 KAM_DMARC_STATUS Test Rule for DKIM or SPF Failure with Strict
Alignment
-0.0 T_SCC_BODY_TEXT_LINE No description available.
1.0 KAM_LAZY_DOMAIN_SECURITY Sending domain does not have any
anti-forgery methods
0.0 FSL_BULK_SIG Bulk signature with no Unsubscribe
2.5 FREEMAIL_FORGED_REPLYTO Freemail in Reply-To, but not From
X-Spam-Flag: YES
Subject: ***SPAM*** PROPOSED PARTNERSHIP.
You will not see this in a MIME-aware mail reader.
--===============0715047031==
Content-Type: text/plain; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
Hello
I'm Dr. Yasunobu Otsuga, CEO of Daito Pharmaceutical, a leading company ba=
sed in Japan. Currently, we're in search of a qualified individual to serve=
as our representative in South Africa for mineral procurement and to spear=
head the establishment of our annex office in the Republic of South Africa.=
This endeavor, spanning a five-year contract, is pivotal in our strategic =
plan to expand our operations and fortify our presence in the South African=
market. If this opportunity intrigues you, please respond, and we'll provi=
de further details. =
Best regards,
Dr. Yasunobu Otsuga
President & CEO
Daito Pharmaceutical Co., Ltd
--===============0715047031==
Content-Type: text/html; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
<HTML><head><meta http-equiv=3D"Content-Type" content=3D"text/html; charset=
=3Diso-8859-1"/></head><BODY><P>Hello</P>
<P>I'm Dr. Yasunobu Otsuga, CEO of Daito Pharmaceutical, a leading company =
based in Japan. Currently, we're in search of a qualified individual to ser=
ve as our representative in South Africa for mineral procurement and to spe=
arhead the establishment of our annex office in the Republic of South Afric=
a. This endeavor, spanning a five-year contract, is pivotal in our strategi=
c plan to expand our operations and fortify our presence in the South Afric=
an market. If this opportunity intrigues you, please respond, and we'll pro=
vide further details. </P>
<P>Best regards,<BR>Dr. Yasunobu Otsuga<BR>President & CEO<BR>Dai=
to Pharmaceutical Co., Ltd</P></BODY></HTML>
--===============0715047031==--